USPTO serial 79219288
Serial No. 79219288
Reviewed by CopyMark Law Group
Reg. 5592411Status 706Registered
- Filing date
- Status date
- Registration date
- Oct 30, 2018
- Examiner
- THOMAS, JULIE
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with Serial No. 79219288?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JANET G RICCIUTI
JANET G RICCIUTI JANET GILBERT RICCIUTI, PC2003 KALORAMA ROAD NWWASHINGTON, DC 20009United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical [ and veterinary ] products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders; [ immunosuppression pharmaceutical and veterinary products; sanitary preparations for medical purposes; Biological preparations for clinical medical use intended for gene therapy and cell therapy; Clinical medical reagents used for gene therapy, genetic testing and diagnosis; Cellular preparations for medical, pharmaceutical or veterinary use for gene therapy and cell therapy; Gene therapy products for the treatment of Wilson disease, metabolic and inherited liver disorders, viral and bacterial infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, diseases of the nervous system, neuro-degenerative disorders, inflammatory and auto-immune diseases and disorders, metabolic system and endocrine system diseases and disorders; Immunosuppression gene therapy products ] | ACTIVE | — |
| 042 | Scientific research services, more particularly in the medical, biomedical, chemical, genetic, pharmaceutical, biotechnological and veterinary fields [ ; computer programming services in the fields of science, pharmacy and medicine ] | ACTIVE | — |
| 044 | Medical services; medical information services provided in particular via the Internet | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by VIVET THERAPEUTICS
- Other trademarks owned by VIVET THERAPEUTICS,
- Other trademarks owned by VIVET THERAPEUTICS,
- Other trademarks owned by VIVET THERAPEUTICS
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 28, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jul 28, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jul 9, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 29, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 29, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Apr 29, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Apr 28, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 17, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 7, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 30, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 16, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 30, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 14, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 26, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 1, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 7, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 7, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 30, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 30, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 14, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 14, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 11, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 25, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 25, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 25, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 7, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 6, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 9, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 9, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 20, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 19, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 31, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 27, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |